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Objectives: Widespread application of infrarenal endovascular aneurysm repair (EVAR) has resulted in a proportionate
increase in open juxtarenal aortic aneurysm (JAA) repairs. Fenestrated endograft technology for JAA is developing
rapidly, but only limited outcomes are known. The aim of this study was to review our open JAA experience in an era of
fenestrated endograft technology, identify factors associated with increased surgical risk, determine early and midterm
outcome, and provide a basis for comparison for future endovascular procedures.
Methods: Data from 126 consecutive patients who underwent elective JAA repair requiring suprarenal aortic clamping
from 2001 to 2006 were analyzed retrospectively. Electronic medical chart reviews were used to record 30-day
complication rates. Multivariate analyses were performed to identify risk factors associated with surgical morbidity.
Mail-out questionnaires and telephone surveys were conducted to determine long-term follow-up.
Results:Ninety-eight males and 28 females (median age 74 years; range 55 to 93) were included in the study. Preoperative
risk factors included: coronary artery disease (CAD) 58%, pulmonary disease 41%, renal insufficiency (serum creatinine
[Cr] > 1.5mg/dL) 17%, and diabetes 9%. Fifteen patients underwent concomitant renal artery revascularization. Mean
operative time was 319 minutes (range 91 to 648). Thirty-day mortality was 1/126 (0.8%). Median hospital length of
stay was 7 days (range 3 to 85); median intensive care unit length of stay was 2 days (1 to 64). Complications included
renal insufficiency (Cr increase> 0.5 mg/dL) in 22 (18%), cardiac in 17 (13%), and pulmonary in 14 (11%). Five patients
required temporary hemodialysis; only one after hospital dismissal. Mean follow-up was 48 months (range 9-80). On
multivariate analysis, age > 78 years (P  .001), male gender (P  .04), hypertension (P .01), previous myocardial
infarction (P  .047), and diabetes (P .009) were predictive of cardiac complications. Renal artery revascularization
(P  .01) and prior MI (P  .04) were multivariate predictors of pulmonary complications. Both prolonged operative
(>351 minutes, P  .02) and renal ischemia (>23 minutes, P .004) times predicted postoperative renal insufficiency.
One, 3, and 5-year cumulative survival rates were 93.9%, 78.3%, and 63.8%, respectively and were not significantly
different than an age- and gender-matched sample of the US population (P  .16). Mortality was not predicted by any
specific risk factors.
Conclusions: Open surgical repair of JAA is associated with low mortality and remains the gold standard. Although 18% had
renal complications, only one patient had permanent renal failure. Patients with a combination of physiologic and anatomic
risk factors identified onmultivariate analysismay benefit from fenestrated endograft repair. (J Vasc Surg 2008;47:695-701.)In the United States, 5% to 7% of people over age 60
years have an abdominal aortic aneurysm (AAA). While
most are infrarenal, 2% to 20% are juxtarenal and extend to
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doi:10.1016/j.jvs.2007.12.007the renal arteries.1-3 Currently, almost 60% of infrarenal
aneurysms have suitable anatomy for endovascular repair
with a commercially available device.4 Consequently, fewer
infrarenal aneurysms are being treated in an open manner.
As a result of this selection bias, a higher percentage of open
aortic surgery now involves more complex repair of aneu-
rysms in the juxtarenal and suprarenal position. Although
the mortality rate for open juxta- and pararenal aneurysm
repair for high volume centers ranges from 1.5% to 7% 5-8 in
contemporary series, data regarding factors predictive of
outcome and survival are sparse.
While fenestrated aortic endografts are now available
for high risk patients, the technique is still in evolution and
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repair of juxtarenal aortic aneurysms (JAA) becomes more
common, it will be important to determine if this approach
provides better outcome than open repair. The objective of
this study was to review our recent experience with elective
open JAA repair from 2001 to 2006, identify factors asso-
ciated with increased surgical risk, and determine early- and
midterm outcome in order to provide a comparison with
endovascular procedures.
METHODS
Clinical data of consecutive hemodynamically stable
patients undergoing elective or urgent open repair of JAA
at the Mayo Clinic from January 1, 2001 to December 31,
2006 were retrospectively collected and analyzed. Patients
with acute or chronic rupture, or leaking aneurysms were
excluded from this analysis. Data were collected through
electronic chart review after appropriate patient authoriza-
tion under a protocol approved by the Institutional Review
Board in compliance with HIPAA standards.
Aneurysm definitions. JAAs are defined as aneurysms
that extend up to but do not include the origin of the renal
arteries and require clamping above one or both renal
arteries. Patients with juxtarenal aneurysms that required
supra-superior mesenteric artery (SMA) or supraceliac
clamping due to extensive calcification or thrombus at or
above the renal arteries were also included. The designation
of an aneurysm as juxtarenal was based on preoperative
radiographic findings and confirmed by intraoperative
anatomy. The study excluded pararenal aortic aneurysms
(involving the orifice of the renal arteries), infrarenal aortic
aneurysms suitable for conventional endovascular aneu-
rysm repair (EVAR), or open repair with an infrarenal aortic
cross clamp.
Preoperative variables. Preoperative renal insuffi-
ciency was defined as serum creatinine values1.5 mg/dL.
Coronary artery disease (CAD) was defined on the basis of
an abnormal stress test, previous myocardial infarction on
electrocardiograph, or a history of coronary artery revascu-
larization (open or percutaneous). Congestive heart failure
(CHF) was defined clinically by a hospital admission for
acute exacerbation or an ejection fraction of 30%.
Chronic obstructive pulmonary disease (COPD) was iden-
tified on pulmonary function studies or ongoing need for
inhaler or steroid treatment. Patients with significant
COPD underwent pulmonary rehabilitation preopera-
tively. Diabetes, hyperlipidemia, and hypertension were
identified in patients undergoing active medical or dietary
treatment. Cerebrovascular disease was considered present
in those with a history of stroke, transient ischemic attack,
or carotid endarterectomy.
Operative conditions and reconstructive techniques.
A transperitoneal midline incision with an infracolic aortic
exposure was used in most cases. In selected patients, a
midline minimal incision laparotomy (15 cm) was per-
formed as described by Turnipseed.9 For those with signif-
icant pulmonary comorbidities or multiple prior abdominal
operations, the juxtarenal aorta was exposed through aretroperitoneal approach. The left renal vein was mobilized
by dividing the lumbar-renal, adrenal, and gonadal veins.
Renal and visceral arteries, when indicated, were isolated
individually and clamped before aortic clamp placement.
Aortic clamps were placed supraceliac, supra-SMA, supra-
renal, or inter-renal (between the two main renal arteries).
All patients were systemically treated with 70 to 100 U/kg
of heparin before aortic clamping.
Methods of reconstructing the proximal anastomosis
included suturing the graft to the juxtarenal aorta in an
end-to-end fashion or spatulating the graft to incorporate
the renal arteries into the suture line. In patients considered
high cardiac risk because of poor left ventricular function
(ejection fraction [EF] 35%) and positive stress echogra-
phy, temporary axillary-femoral bypass was performed to
allow afterload reduction during aortic clamping. The graft
was not tunneled and the graft stumps were over sewn after
removal of the graft at the end of the procedure.
Renal protection included intravenous mannitol (12.5
to 25 g) and furosemide (40 to 60 mg) to induce diuresis
before the initial aortic clamp placement, followed by direct
renal artery instillation with cold renal solution (12.5 g
mannitol and 5000 units of heparin into one liter of Lac-
tated Ringer’s solution) every 15 minutes in most cases.
Renal artery revascularization was performed by endarter-
ectomy in patients with concomitant renal artery stenosis.
Reimplantation of prior renal artery bypass grafts and sig-
nificant accessory renal arteries (3 mm) to the aortic graft
were performed when indicated. Bypass grafting to the
renal arteries was used exclusively for renal salvage. No
renal arteries in this series were revascularized because of
involvement with aneurysmal aorta. Intraoperative comple-
tion studies included ultrasound for all patients undergoing
renal endarterectomy, and either ultrasound or ultrasonic
flow measurements (mL/min), or both, for patients with
renal artery bypass.
Renal ischemia times refer to time from aortic clamp
placement until the last renal artery was reperfused. In the
case of renal artery bypass, the ischemia time for each
kidney was recorded separately. In cases where the clamp
was placed inter-renal, the ischemia time refers to single
renal ischemia. Volume of blood transfused intraopera-
tively was recorded in units transfused and included both
cell saver and banked blood.
Morbidity and mortality. The primary study end
point was 30-day mortality; secondary end points were major
renal, cardiac, and pulmonary complications. The normal
serum creatinine value was chosen as 1.5 mg/dL.10 Renal
insufficiency was defined as a rise in serum creatinine by0.5
mg/dL above baseline. Patients with postoperative renal in-
sufficiency were further categorized as recovered vs persistent
renal insufficiency based on success or failure of creatinine to
return to1.5mg/dL or within 30% of preoperative baseline
serum creatinine value at the time of hospital discharge. Car-
diac complications included cardiac arrhythmias requiring
treatment with negative chronotropic agents and myocardial
infarction (MI) defined by elevation of biochemical markers
and/or electrocardiographic evidence of myocardial injury.
JOURNAL OF VASCULAR SURGERY
Volume 47, Number 4 Knott et al 697Pulmonary failure was defined as ventilator dependence of
72 hours, need for postoperative reintubation, clinical data
or culture confirmation of pneumonia, or the need for trache-
ostomy.
Follow-up. Electronic medical records were reviewed
to obtain disposition after hospital discharge and subse-
quent follow-up information. Telephone and mail surveys
were used to establish time to return to preop level of
activity, current level of activity, and disposition after hos-
pital discharge.
Data analysis. Continuous variables are summarized
with the mean  standard deviation or median (range).
Categoric variables are summarized with frequencies and
percentages.
Analysis of variables associated with hospital length of
stay and intensive care unit (ICU) length of stay excluded
one patient who died in-hospital. These analyses used
Spearman’s rank correlation in the case of continuous vari-
ables and Wilcoxon rank-sum tests in the case of binary
variables. Multiple linear regression modeling of these two
outcomes was performed on the ranks of the values because
of strongly skewed distributions for the length-of-stay vari-
ables. Analysis of binary outcomes such as pulmonary com-
plications, cardiac complications, and postoperative renal
insufficiency was performed by using univariate and multi-
ple logistic regression analysis and results were reported
with odds ratios and 95% confidence intervals (CIs). Renal
insufficiency analyses excluded two patients on dialysis pre-
operatively.
Variables with univariate P values 0.1 were considered
in multivariable models, which also adjusted for age and
gender. Stepwise model selection procedures were used to
determine the final multivariable models. P values .05 were
considered statistically significant for all analyses;multivariable
models retained variables with trends (P  0.1) as well. To
ease interpretation of odds ratios, continuous variables were
dichotomized in the finalmodels. Specifically, agewas dichot-
omized based on the 75th percentile, while renal ischemia and
operative times were dichotomized based on the optimal
cutpoint as determined by receiver operating characteristic
(ROC) analysis.
Statistical analysis was performed using SAS (version
9.1) software (SAS Institute, Inc, Cary, NC), except for the
comparison of observed survival with expected survival in
the US population with the same age and gender distribu-
tion and similar follow-up time. This analysis was per-
formed using Splus (Version 6, Insightful Corp., Seattle,
Wash), and the method described by Therneau et al.11
RESULTS
Patient demographics. Between January 1, 2001,
and December 31, 2006, 1535 AAAs were repaired at the
Mayo Clinic. Juxtarenal aortic aneurysms accounted for
8.2% (126/1535) of all AAAs repaired. There were 98 men
(78%) and 28 women (22%), with a mean age of 73.6 years
(range, 55 to 93) and form the basis of this report. Sixty-
one of these patients were also included in an earlier report
on pararenal aortic aneurysms from our institution.12Preoperative variables. Risk factors for atheroscle-
rotic vascular disease and comorbidities are summarized in
Table I. Aneurysm etiology was described in all patients and
included degenerative in 118 (94%), inflammatory seven
(5.6%), and infected in one (0.8%). Fourteen patients
(11%) had symptomatic aneurysms and six of these were
treated within 24 hours of presentation. Mean aneurysm
size was 6.25 cm (median, 6; range 4.3 to 11).
Operative details. Surgical approach was midline,
transabdominal in 107 patients (85%) of whom 12 (9.5%)
had a minimal incision laparotomy, and retroperitoneal in
19 (15%). Aortic reconstructions were straight grafts in 69
(55%) and bifurcated in 57 (45%). Clamp placement sites
and renal and mesenteric ischemia times are summarized in
Table II.
Twenty-three concomitant renal artery reconstructions
were required in 15 patients (12%) (Table II); nine patients
had both renal arteries revascularized including two pa-
tients with a combination of procedures (reimplantation of
a prior iliorenal artery bypass graft and unilateral endarter-
ectomy, n 1; reimplantation of accessory renal artery and
unilateral endarterectomy, n  1). Reimplantation of a
Table I. Preoperative comorbidities
Comorbidities Patients, n (%)
History of tobacco use 110 (87)
Hypertension 106 (84)
Hyperlipidemia 79 (63)
Coronary heart disease 73 (58)
COPD 52 (41)
Previous myocardial infarction 42 (33)
Serum creatinine 1.5 mg/dL 22 (17)
Cerebrovascular disease 20 (16)
Congestive heart failure 14 (11)
Diabetes mellitus 11 (9)
Preoperative dialysis 2 (1.6)
COPD, Chronic obstructive pulmonary disease.
Table II. Operative variables
Operative variables Patients, n (%)
Clamp location
Supraceliac 5 (4)
Supra-SMA 21 (17)
Suprarenal 100 (79)
Bilateral 56 (44)
Inter-renal 44 (35)
Renal artery proceduresa 15 (12)
Endarterectomy alone 10 (8)
Reimplantation alone 1 (1)
Bypass alone 2 (2)
Combination 2 (2)
Renal ischemia time (min) 22.5  10.3 (3-90)b
Mesenteric ischemia time (min)c 9.3  12.7 (3-42)b
SMA, Superior mesenteric artery.
a23 procedures in 15 patients.
bMean  SD (range).
c26 patients with supraceliac or supra-SMA clamp location.significant accessory renal artery was performed in one
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renal artery bypasses with Dacron graft in two (1.5%). One
patient required renal artery bypass due to embolization
after completion of the proximal anastomosis and the sec-
ond due to diminished flow after repair of a tear in the
native aorta. Median renal ischemia times for endarterec-
tomy were 29minutes; for reimplantation, 35 minutes; and
for renal artery bypass, 32 minutes. Left renal vein division
and reanastomosis was required in one patient. Five pa-
tients (4%) had inferior mesenteric artery reimplantation.
The mean operative time was 319 minutes (range 91 to
648), and 4.8 units (banked blood plus autotransfusion)
was the mean blood volume transfused intraoperatively.
Morbidity andmortality. Both 30-day and in-hospital
mortality were 0.8% (1/126). There was one death after
retroperitoneal repair due to intra-abdominal hemorrhage
from an unrecognized splenic injury. Cardiac complica-
tions includedMI in seven (6%) and arrhythmia in 10 (8%).
Pulmonary complications occurred in 14 (11%) and post-
operative renal insufficiency occurred in 22 of 124 (18%)
patients (Table III); temporary in-hospital hemodialysis
(HD)was required in five (4%), excluding two patients who
were on dialysis preoperatively. Of 22 patients, six patients
(27%) had undergone concomitant renal artery revascular-
ization (bilateral endarterectomy  2, unilateral endarter-
ectomy  1, unilateral bypass  1, reimplant/unilateral
endarterectomy  1, combination  1). Renal artery re-
construction was associated with a greater risk of postoper-
ative renal insufficiency (P  .04) on univariate analysis.
However, elevated preoperative serum creatinine was not
predictive of postoperative renal insufficiency (P  .14) or
need for postoperative temporary HD, which occurred in
5% (1/21) vs 4% (4/104) of those with normal preopera-
tive serum creatinine (P  1.0). Nineteen of 22 (86%)
patients with postoperative renal insufficiency had return of
creatinine to1.5 mg/dL or within 30% of baseline at the
time of hospital discharge. One of three patients with
persistent renal insufficiency remained on HD at time of
discharge. This patient had a baseline preoperative serum
creatinine of 3.6 mg/dL.
The level of aortic clamp placement (supravisceral vs
suprarenal; supravisceral vs inter-renal) had no significant
Table III. Postoperative complications
Morbiditya Patients, n (%)
Renal insufficiencyb 22 (18)
Dialysisb
Temporary 5 (4)
Permanent 1 (1)
Cardiac complication 17 (14)
Myocardial infarction 7 (6)
Arrhythmia 10 (8)
Pulmonary complication 14 (11)
Mesenteric ischemia 3 (2)
aExcluding one patient who died postop day zero.
bExcluding two patients dialysis preoperatively.effect on the development of cardiac, pulmonary, or renalcomplications. Additionally, there was no difference in
postoperative renal insufficiency between patients with su-
prarenal or inter-renal aortic clamp placement (13% vs 19%,
respectively; P  .42).
Three patients had colon ischemia confirmed by flexible
sigmoidoscopy; two withmild, superficial erosions wereman-
aged conservatively and the other with full thickness necrosis
and sepsis required sigmoid resection and end colostomy.
One patient with acalculous cholecystitis was treated with a
percutaneous cholecystostomy tube. Median hospital length
of stay was 7 days; details are listed in Table IV.
Clinical predictors. The risk factors associated with
postoperative complications on multivariate analysis are
listed in Table V. No associations were identified between
preoperative characteristics or surgical data and 30-day
mortality since only one event occurred. Table IV summa-
rizes the factors associated with prolonged length of stay on
multivariate analysis.
Follow-up. Disposition after hospital discharge was
to home in 110 patients (87%), nursing home in nine
(7%), and an in-hospital rehabilitation unit in five (4%).
All aortic grafts remained patent and no patient devel-
oped additional aortic aneurysms or pseudoaneurysms.
Thirteen of 23 renal arteries (57%) in 6/14 patients
(43%) who underwent renal artery revascularization had
imaging available for review at a mean of 717 days (range
117 to 1849). Eleven of 13 renal arteries were patent.
One reimplanted iliorenal bypass graft and one endarter-
ectomized renal artery occluded during follow-up. One
patient with preoperative serum Cr  2.0 mg/dL pro-
gressed to hemodialysis at 4.75 years after JAA repair. Of
note, this patient did not develop postoperative renal
insufficiency.
Functional outcome was assessed in 66 of the 105
patients (63%) alive at the end of the study period at a mean
follow-up was 48 months (range, 9 to 80). Level of activity
was normal or mildly limited in 82% while the remainder
(18%) reported significant limitation of daily activities but
was still living at home.
Kaplan-Meier estimate of survival (Fig) for open JAA
repair at 1, 3, and 5 years was 94%, 78%, and 64%, respec-
tively. There was no significant difference in survival when
compared with an age- and gender-matched sample of the
general US population (P  .16).
DISCUSSION
The inherent complexity and risks of open JAA repair
are higher than standard repair of infrarenal aneurysms with
greater concern for renal morbidity postoperatively. Due to
the anatomy of JAA, clamping above one or both renal
arteries is required. If extensive thrombus or calcification is
present in the pararenal aorta, more proximal control above
the visceral vessel(s) may be required. Therefore, the higher
the level of aortic clamping, the greater the risks of cardiac
stress, renal and visceral ischemia/reperfusion, and distal
embolization.7,10 The first report specifically addressing
JAA was by Crawford et al in 1986.1 The mortality rate was
7.9% and 8% of patients became dialysis dependent. The
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juxtarenal aneurysms, published in 1999 from the Univer-
sity of California San Francisco, concluded that these aneu-
rysms could be safely repaired with low mortality (5.8%)
but with increased renal morbidity (41%) and permanent
hemodialysis in 4.3%.10 A more contemporary analysis of
open JAA repair from the Cleveland Clinic revealed a
mortality of 5.1%, transient renal insufficiency in 28% with
need for hemodialysis in 5.8% of patients.13 In a recent
review of factors affecting outcome of open repair of para-
and juxtarenal aneurysms in 247 patients from our institu-
tion, West and colleagues12 reported low mortality (2.5%),
but significant renal morbidity with transient renal insuffi-
ciency in 22% and new hemodialysis in 3.7% of patients.
The results of the present series compare favorably with
those in the literature with an operative mortality of 0.8%,
renal insufficiency in 18%, and newHD in 4% of patients. The
low30-daymortality in the current report is not different from
that for endovascular and open infrarenal aortic aneurysm
repair (1.6%) at our institution (unpublished data). In addi-
tion, there was no significant difference in preoperative co-
morbidities between patients with juxta- or infrarenal aneu-
rysms undergoing open repair. In addition to the
contemporary nature of this series which aims to provide a
baseline for comparison with fenestrated endograft repair, no
Table IV. Length of stay data
Median/mean length of stay (
ICU length of stay 2/4.6 d (1-64)
Hospital length of stay 7/16.7 d (3-86)
ICU, Intensive care unit.
aExcluding one patient who died postop day zero.
Table V. Multivariate logistic regression results
Outcome and variables Odds ratio (95% CI) P
Renal insufficiencya,b
Operative time  351 min 3.5 (1.2, 10.2) .02
Renal ischemia  23 min 4.5 (1.6, 14.3) .004
Cardiac complicationsa
Age  78 y 8.3 (2.3, 36.6) .002
Male gender 6.4 (1.1, 125.4) .04
Hypertension NA (2.0, NA) .01
Diabetes 8.2 (1.7, 43.8) .009
Previous myocardial infarction 3.4 (1.0, 12.7) .047
Pulmonary complicationsa
Renal artery revascularization 8.4 (1.7, 44.0) .01
Previous myocardial infarction 3.5 (1.1, 12.6) .04
CI, Confidence interval.
aExcluding one patient who died postop day zero.
bExcluding two patients on dialysis preoperatively.doubt the more aggressive preoperative risk factor modifica-tion and treatment account in part for the excellent re-
sults.14-16 The single operative death in this series was second-
ary to hemorrhage from unrecognized splenic trauma.
Hemorrhage and visceral ischemia were also major contribu-
tors to mortality in other series.10,13 However, some au-
thors7,13,17 have found an association of advanced age, CAD,
clamp position, and postoperative coronary events with peri-
operative mortality. No factors associated with open JAA
repair predicted mortality in our current report.
The ideal level of aortic cross clamp placement remains
controversial with conflicting views reported in the literature.
Some authors8,17 have recommended supraceliac clamping to
avoid complications related to proximal aortic cuff disease for
both juxta- and pararenal aneurysm repair. In a series of JAA
repairs where 83% (92/112) of cases involved clamping of the
supra-celiac aorta, Shortell et al advocated this level for JAA
repair.8 Themortality in this series was 6.1% with five of seven
deaths directly attributable to postoperative MI. Others5,6,10
have specifically noted no difference inmortality related to the
level of aortic clamping (suprarenal vs supravisceral). In fact,
Sarac et al reported significantly greater mortality in patients
with supravisceral vs suprarenal aortic clamping (11.6% vs
Fig. Kaplan-Meier estimate of observed survival in patients under-
going open juxtarenal aortic aneurysms (JAA) repair (solid line)
compared with an age- and gender-matched sample of the US
population (dashed line).
e) Multivariate linear regression P
Cardiac complicationsa .0003
Pulmonary complicationsa .0003
Blood volume transfused .0006
Total operative time .007
Cardiac complicationsa .002
Pulmonary complicationsa .0001
Blood volume transfused .0045rang2.1%, respectively) on multivariate analysis in their report of
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supravisceral clamping in our present analysis and recommend
clamping the aorta at this level only if extensive thrombus
and/or calcification make suprarenal clamping prohibitive.
The incidence of cardiac complications in our series was
in keeping with reports in the literature with myocardial
infarction in 6% of patients.13 Cardiac complications were
associated with the usual unavoidable risk factors indige-
nous to the population most likely to have aneurysmal
disease: age 78 years, male gender, hypertension, diabe-
tes, and previous myocardial infarction. A useful adjunct in
patients at high risk for developing myocardial ischemia
during aortic clamping is the placement of a temporary
conduit to offload the left ventricle during aortic clamp-
ing.18 Three per cent (4/126) of our patients with an EF
35% (range 15% to 35%) had a temporary axillo-femoral
conduit placed prior to aortic clamping. One patient (EF
30%) required supra-SMA clamping while the remaining
three were suprarenal. Though the average operative time
was longer in these patients (353 minutes with conduit vs
318minutes without), none suffered any procedure-related
cardiac complications and hospital length of stay was not
longer (median 8.75 days with conduit vs 7 days without).
Following any type of aortic reconstruction, the most
common morbidity associated with decreased long-term
survival is renal insufficiency.19 The reported incidence of
renal complications associated with aortic reconstruction
requiring clamping above the renal arteries ranges from
3.1% to 61%2,3,5,13,20 with 0% to 3.8%6,12,13,21 requiring
permanent dialysis. Our results are in agreement with a
significant increase in postoperative serum creatinine oc-
curring in 18% of patients and permanent dialysis in 1
(0.8%). Preoperative renal dysfunction and prolonged renal
ischemia times have been repeatedly shown to be associated
with postoperative renal insufficiency; the former even pre-
dictive of persistent long-term deterioration of renal func-
tion.5,6,10,13 However, only prolonged operative (351
minutes) and renal ischemia times (23 minutes) were
predictive factors. Although mesenteric ischemia has been
shown repeatedly to be a predictor of poor outcome in
many juxta- and pararenal aneurysm series,8,10,12 the three
who developed clinical ischemia in this series had suprare-
nal aortic clamping.
Length-of-stay after JAA repair in our series was not
significantly different from what is reported in the litera-
ture.13 Both cardiac and pulmonary complications com-
bined with increased transfusion requirement predicted
prolonged length of stay. Surprisingly, postoperative renal
insufficiency was not found to increase length of stay and
this may reflect the overall lower incidence of this compli-
cation in our patient sample. Despite prolonged length of
stay for JAA compared with infrarenal aneurysm repair,22,23
a comparable proportion of patients (87%) were discharged
to home after hospitalization. In addition, midterm survival
at 3 years was 78% in this patient cohort compared with 87%
for EVAR and 81% for open infrarenal aneurysm repair at
our institution (unpublished data). In fact, estimated sur-
vival in these patients was not significantly different fromage- and gender-matched controls at least as far out as 5
years following repair.
As with all retrospective reviews, our report has certain
limitations. While the general guidelines in the manage-
ment of JAA were followed, variables such as surgical
technique and indications for elective surgery were left to
the discretion of the vascular surgeon performing the op-
eration. We reported only patients with JAA who under-
went repair, therefore there may be a small group of pa-
tients that were of such high cardiac and/or pulmonary risk
that were not considered suitable surgical candidates. Fe-
nestrated endografts designed specifically to address the
anatomic challenges of juxtarenal aortic aneurysms are now
available and may potentially provide a safe alternative for
repair in this subset of patients.
The early and midterm results of fenestrated devices are
quite favorable with 1% to 2.6% 30-day mortality, 10% inci-
dence of endoleak, and 92% visceral branch patency.24-26 As
with EVAR for infrarenal aortic aneurysms, close surveillance
is required not only for monitoring of aneurysm exclusion,
graft migration, and endoleaks, but for delayed occlusions of
renal and visceral arteries with associated renal dysfunction
and symptomatic mesenteric ischemia.26 As safety and dura-
bility of fenestrated grafts is established and availability be-
comeswidespread, therewill be a tendency forwidespread use
especially with well-informed patients demanding aminimally
invasive alternative to open surgical repair. The challenge that
will remain will be appropriate patient selection and whether
this technique should be extended to good risk surgical can-
didates. The results of open JAA repair in this series contem-
porary to an era of available fenestrated endografts may serve
to identify patients who would benefit from endovascular vs
open repair.
In conclusion, contemporary open repair of JAA in the
era of evolving fenestrated endograft technology is safe,
effective, and durable, even in patients with multiple car-
diovascular risk factors. Renal and pulmonary complica-
tions can potentially be reduced by minimizing operative
and renal ischemia times. Male patients over 78 with dia-
betes, hypertension, and previous myocardial infarction are
at higher risk of cardiac complications. Identification of
patients with a combination of these anatomic and physio-
logic factors predicting cardiac, renal and pulmonary com-
plications may help define a subgroup of patients who
would benefit from fenestrated endograft technology.
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